IU Health Bloomington Clinical Research

IU Health Bloomington understands that clinical research is an important contributor to patient satisfaction and improved clinical outcomes.

The hospital is committed to aggressively developing a robust research environment in order to better serve the surrounding community and improve access to care throughout the IU Health system.

Our commitment to developing and maintaining a collaborative research environment allows our physicians to explore a variety of treatment options and allows them to provide cutting-edge therapies to their patients.

Below is a list of the clinical trials available for participation at IU Health Bloomington. Please contact the IU Health Bloomington research office 812.353.2831 or BLM-ClinicalResearch@IUHealth.org for more information.

Myelodysplastic Syndromes and Acute Myeloid Leukemia

CONNECT PI – Danielle Doyle, MD

The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

More information about this study

The Breast Cancer Weight Loss (BWEL) Study

Dr. David Lee

Randomized Phase III Trial Evaluating the Role of Weight Loss In Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer (Alliance 011401)

More information about this study

Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation

Stop AF First

John Strobel, MD and Kyle Hornsby, MD

To provide data demonstrating the safety and effectiveness of the Arctic Front Advance™ Cardiac Cryoablation Catheter for the treatment of recurrent symptomatic paroxysmal atrial fibrillation, without the requirement that the subjects be drug refractory.

More information about this study

AVA-CIT-330

Karuna Koneru, MD

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Active Non-Hematological Cancers.

More information about this study

Connect-HF

Kevin Zawacki, MD

A large-scale, pragmatic, cluster-randomized clinical trial to evaluate the effect of a customized, multifaceted, health system-level quality-improvement (QI) program compared with usual care on heart failure (HF) outcomes and HF quality-of-care metrics.

More information about this study

Transform

Gregory Heumann, MD

A large-scale, pragmatic, randomized, unblinded clinical effectiveness study comparing torsemide versus furosemide as treatment for heart failure. Approximately 6,000 patients with heart failure will be enrolled. The primary objective is to compare the treatment strategy of torsemide versus furosemide on clinical outcomes over 12 months in patients with heart failure who are hospitalized.

More information about this study

As of March 1, 2017, IRB oversight of human subjects research conducted at IU Health Bloomington Hospital will be provided by the Indiana University IRBs.

The IU IRBs are administered and supported by the IU Human Subjects Office (HSO), which currently serves all eight IU campuses and IU Health locations in the Indianapolis area and around the state, among others.

Visit the HSO website

Institutional Review Board

As of March 1, 2017, IRB oversight of human subjects research conducted at IU Health Bloomington Hospital will be provided by the Indiana University IRBs.

The IU IRBs are administered and supported by the IU Human Subjects Office (HSO), which currently serves all eight IU campuses and IU Health locations in the Indianapolis area and around the state, among others.

Visit the HSO website